Induction and Maintenance Infliximab Therapy for the Treatment of Moderate-to-Severe Crohn’s Disease in Children
Jeffrey S. Hyams(Connecticut Children's Medical Center), Wallace Crandall(Nationwide Children's Hospital), Subra Kugathasan(Medical College of Wisconsin), Anne M. Griffiths(Hospital for Sick Children), Allan Olson, Jewel Johanns, Grace Liu, Suzanne Travers, Robert Heuschkel(University College London), James Markowitz(Northwell Health), Stanley A. Cohen(Children's Center), Harland S. Winter(Massachusetts General Hospital), G. Veereman‐Wauters(Queen Fabiola Children's University Hospital), George D. Ferry(Texas Children's Hospital), Robert N. Baldassano(Children's Hospital of Philadelphia)
Cited by 868
Abstract
Related Papers
Evaluation of the Pediatric Crohn Disease Activity Index: A Prospective Multicenter Experience
Jeffrey S. Hyams, James Markowitz, Anthony Otley et al.|Journal of Pediatric Gastroenterology and Nutrition|2005|329